Julio
García Suárez
Profesor/a Titular Universidad
Hospital Ramón y Cajal
Madrid, EspañaPublicacións en colaboración con investigadores/as de Hospital Ramón y Cajal (12)
2024
-
COVID-19 Outcomes in Patients with Hematologic Malignancies in the Era of COVID-19 Vaccination and the Omicron Variant
Cancers, Vol. 16, Núm. 2
-
Outcomes after intensive chemotherapy for secondary and myeloid-related changes acute myeloid leukemia patients aged 60 to 75 years old: a retrospective analysis from the PETHEMA registry
Haematologica, Vol. 109, Núm. 1, pp. 115-128
2023
-
Breakthrough invasive fungal infection among patients with haematologic malignancies: A national, prospective, and multicentre study
Journal of Infection, Vol. 87, Núm. 1, pp. 46-53
-
COVID-19 Severity and Survival over Time in Patients with Hematologic Malignancies: A Population-Based Registry Study
Cancers, Vol. 15, Núm. 5
2021
-
Risk factors and mortality of COVID-19 in patients with lymphoma: A multicenter study
HemaSphere, Vol. 5, Núm. 3, pp. 1-8
-
Severe infections in patients with lymphoproliferative diseases treated with new targeted drugs: A multicentric real-world study
Cancer Medicine, Vol. 10, Núm. 21, pp. 7629-7640
2020
-
Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: Lessons from a large population-based registry study
Journal of Hematology and Oncology, Vol. 13, Núm. 1
2019
2012
-
Response to imatinib mesylate in patients with hypereosinophilic syndrome
International Journal of Hematology, Vol. 96, Núm. 3, pp. 320-326
2010
2001
-
Translocation t(4; 6)(q21; q27) in a case of primary thrombocythaemia in transformation
Clinical and Laboratory Haematology, Vol. 23, Núm. 4, pp. 259-260
1991
-
SYSTEMIC MASTOCYTOSIS AND PRIMARY THROMBOCYTHAEMIA
British Journal of Haematology